These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32464405)

  • 1. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
    Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
    J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
    Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
    Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
    Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation.
    Chen R; Zhang H; Ma T; Xue H; Miao Z; Chen L; Shi X
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2635-2637. PubMed ID: 31358466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
    Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
    Aziz Ali A; Gogoi D; Chaliha AK; Buragohain AK; Trivedi P; Saikia PJ; Gehlot PS; Kumar A; Chaturvedi V; Sarma D
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3698-3703. PubMed ID: 28712709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
    Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
    Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
    Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
    Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.